,i  #aacth ,,congress  #b;d ,session    
,h4 ,r4 #dgji  ,,in ,,the ,,house ,,of  
,,representatives  ,may #ba1 #bjad ,mr4 
,marino 7for himself1 ,mrs4 ,blackburn1 
,mr4 ,welch1 and ,ms4 ,chu7 introduced  
the following bill2 which was referred  
to the ,committee on ,energy and        
,commerce1 and in addition to the       
,committee on the ,judiciary1 for a     
period to be subsequently determined by 
the ,speaker1 in each case for          
consideration of such provisions as fall
 within the jurisdiction of the         
committee concerned  ,a ,,bill  ,to     
improve enforcement efforts related to  
prescription drug diversion and abuse1  
and for other purposes4  #a4 ,short     
title ,this ,act may be cited as the    
,ensuring ,patient ,access and          
,effective ,drug ,enforcement ,act of   
#bjad4  #b4 ,registration process under 
,controlled ,substances ,act  7a7       
,definitions  7#a7 ,consistent with the 
public health and safety ,section #cjc  
of the ,controlled ,substances ,act 7#ba

 ,u4,s4,c4 #hbc7 is amended by adding at
 the end the following3  7j7 ,in this   
section1 the phrase consistent with the 
public health and safety means having a 
substantial relationship to this ,act's 
purpose of preventing diversion and     
abuse of controlled substances4  4  7#b7
 ,imminent danger ,section #cjd7;d7 of  
the ,controlled ,substances ,act 7#ba   
,u4,s4,c4 #hbd7;d77 is amended--  7,a7  
by striking 7d7 ,the ,attorney ,general 
and inserting 7d77#a7 ,the ,attorney    
,general2 and  7,b7 by adding at the end
 the following3  7#b7 ,in this          
subsection1 the term imminent danger    
means a significant and present risk of 
death or serious bodily harm that is    
more likely than not to occur in the    
absence of an immediate suspension      
order4  4  7b7 ,opportunity ,to submit  
corrective action plan prior to         
revocation or suspension ,section       
#cjd7;c7 of the ,controlled ,substances 
,act 7#ba ,u4,s4,c4 #hbd7;c77 is        
amended--  7#a7 by striking 7c7 ,before 

and inserting 7c77#a7 ,before2 and  7#b7
 by adding at the end the following3    
7#b7 ,before revoking or suspending a   
registration pursuant to section #cjc1  
the ,attorney ,general shall--  7,a7    
provide--  7i7 notice to the registrant 
of the grounds for revocation or        
suspension2 and  7ii7 in the case of any
 such grounds consisting of a violation 
of law1 a specific citation to such law2
  7,b7 give the registrant an           
opportunity to submit a corrective      
action plan within a reasonable period  
of time to demonstrate how the          
registrant plans to correct the grounds 
for revocation or suspension2 and  7,c7 
determine whether--  7i7 in light of the
 plan1 revocation or suspension         
proceedings should be discontinued or   
deferred2 or  7ii7 additional changes   
need to be made in the corrective action
 plan4  4  #c4 ,report to ,congress on  
effects of law enforcement activities on
 patient access to medications  7a7 ,in 
general ,not later than one year after  

the date of enactment of this ,act1 the 
,secretary of ,health and ,human        
,services1 acting through the           
,commissioner of ,food and ,drugs and   
the ,director of the ,centers for       
,disease ,control and ,prevention1 and  
in consultation with the ,administrator 
of the ,drug ,enforcement               
,administration and the ,director of    
,national ,drug ,control ,policy1 shall 
submit a report to the ,congress--  7#a7
 assessing how patient access to        
medications could be adversely impacted 
by ,federal and ,state law enforcement  
activities2 and  7#b7 identifying how   
collaboration between agencies and      
stakeholders can benefit patients and   
prevent diversion and abuse of          
controlled substances4  7b7             
,consultation ,the report under         
subsection 7a7 shall incorporate        
feedback and recommendations from the   
following3  7#a7 ,patient groups4  7#b7 
,pharmacies4  7#c7 ,manufacturers of    
drugs4  7#d7 ,common or contract        

carriers and warehousemen4  7#e7        
,hospitals1 physicians1 and other health
 care providers4  7#f7 ,state attorneys 
general4  7#g7 ,law enforcement         
officials1 including local law          
enforcement officials4  7#h7 ,health    
benefit plans and entities that provide 
pharmacy benefit management services on 
behalf of a health benefit plan4  7#i7  
,wholesale drug distributors4